Reilly Financial Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
$5K Buy
68
+18
+36% +$1.32K ﹤0.01% 824
2021
Q3
$6K Buy
+50
New +$6K ﹤0.01% 718